Clinical Trials Sponsored by EKOS Corporation

Total 6517 results

Boston Scientific Corporation
EKOS Corporation

Withdrawn

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Coronary Artery Disease | Atherosclerosis | Peripheral Artery Disease | Chronic Total Occlusion

United States
Boston Scientific Corporation
EKOS Corporation

Completed

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System (ACCESS PTS)

Deep Vein Thrombosis | Post-thrombotic Syndrome

United States
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland
Boston Scientific Corporation
EKOS Corporation

Completed

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Spectrum Health Hospitals
EKOS Corporation

Completed

Long Term Effects of Treating Submassive Pulmonary Embolism With Ultra-sound Accelerated Thrombolysis (SPEAR)

Submassive Pulmonary Embolism

United States
Krishna Mannava, MD, FACS, RPVI
EKOS Corporation

Unknown

Submassive Pulmonary Embolism Experience With EKOS (SPEEK)

Pulmonary Embolism | Thrombolytic Therapy | Thrombolysis | Mechanical Thrombolysis

United States
Ekso Bionics

Completed

Exoskeleton Treatment of Deconditioning Due to Limited Ambulation Caused by Illness or Injury

Debility Due to Disease

United States
LeKos LLP

Recruiting

EVALUATION OF THE EFFECTIVENESS AND SAFETY OF DOSPRAY® NAZAL SPRAY IN THE SYMPTOMATIC TREATMENT OF PERSISTENT ALLERGIC RHINITIS: A POST-REGISTRATION OBSERVATION STUDY

Allergic Rhinitis

Kazakhstan
Ekso Bionics

Terminated

Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment

Spinal Cord Injuries

United States
Mekos Laboratories AS

Unknown

Quaternium-15, Use Test

Allergic Contact Dermatitis Towards Quaternium-15

Denmark
Mekos Laboratories AS

Completed

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

Allergic Contact Dermatitis

Denmark
Mekos Laboratories AS

Completed

Clinical Evaluation of Bacitracin

Allergic Contact Dermatitis

United States
Kos Pharmaceuticals

Completed

The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC

Intermittent Claudication | Peripheral Vascular Disease

United States
Kos Pharmaceuticals

Completed

Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

Stroke | Diabetes | Atherosclerosis | Dyslipidemia | Coronary Heart Disease
Kos Pharmaceuticals

Completed

Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication

Intermittent Claudication | Peripheral Vascular Disease
Kos Pharmaceuticals

Completed

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)

Hypercholesterolemia
Kos Pharmaceuticals

Completed

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

Hypercholesterolemia
Eko Devices, Inc.

Completed

Development of an Algorithm to Differentiate Heart Murmurs Using Electronic Stethoscopes

Aortic Valve Stenosis | Mitral Regurgitation | Heart Murmurs | Tricuspid Regurgitation | Murmur, Heart | Innocent Murmurs

United States
Eko Devices, Inc.

Completed

Low Ejection Fraction in Single Lead ECG- Ochsner

Heart Diseases | Cardiovascular Diseases | Ventricular Dysfunction | Left Ventricular Dysfunction

United States
Eko Devices, Inc.

Completed

Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence (DAVID1)

Left Ventricular Dysfunction

United States
Eko Devices, Inc.

Terminated

Heart Failure Monitoring With Eko Electronic Stethoscopes (HOME0)

Heart Failure | Heart Failure With Preserved Ejection Fraction | Crackles

United States
Eko Devices, Inc.

Recruiting

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

Pulmonary Hypertension

United States
Eko Devices, Inc.

Recruiting

Real-World Evaluation of Eko Algorithms in a Point of Care Setting

Atrial Fibrillation | Heart Murmurs | Murmur, Heart | Innocent Murmurs | Pathologic Murmur

United States
Eko Devices, Inc.

Recruiting

Real-World Evaluation of Eko Murmur Analysis Software in a Point of Care Setting

Heart Murmurs | Murmur, Heart | Innocent Murmurs | Pathologic Murmur

United States
Eko Devices, Inc.

Completed

Detection of Heart Conditions Using Artificial Intelligence

Heart Failure | Left Ventricular Dysfunction

United States
Eko Devices, Inc.

Completed

Low Ejection Fraction in Single Lead ECG

Heart Diseases | Cardiovascular Diseases | Ventricular Dysfunction | Left Ventricular Dysfunction

United States
Cerebra Medical
Ekosi Health Centre

Recruiting

Assessment of Sleep Quality in Cannabinoid Therapy

Poor Sleep Quality

Canada
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Ekso Bionics
Burke Medical Research Institute

Completed

The WISE Trial - Walking Improvement for SCI With Exoskeleton (WISE)

Injuries, Spinal Cord

United States
Enos Bernasconi

Active, not recruiting

Convalescent Plasma for COVID-19

COVID | Blood Plasma Therapy

Switzerland
Ekso Bionics
Glostrup University Hospital, Copenhagen

Completed

Performance Attributes and User Progression While Using Ekso

Spinal Cord Injury

Denmark, Germany, Netherlands, Norway, Spain, Sweden, Switzerland
In His Image
Kos Pharmaceuticals

Completed

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

Dyslipidemia | Hyperlipidemia | Mixed Hyperlipidemia

United States
Columbia University
EOS imaging Inc.

Unknown

Value of 3D Modeling in Spine Surgery

Scoliosis

United States
University of Pennsylvania
Kos Pharmaceuticals

Completed

Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL

Metabolic Syndrome

United States
University of Louisville
Eko Devices, Inc.

Recruiting

Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST) (BEA-BEST)

Acute Respiratory Failure

United States
University Hospital, Bordeaux
EOS imaging Inc.

Completed

Postural Balance of the Adult (POSTURADULT)

Postural Balance

France
Virginia Commonwealth University
Eko Devices, Inc.

Not yet recruiting

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

Tachyarrhythmia

United States
Children's Hospital of Philadelphia
EOS imaging Inc.

Completed

Adolescent Idiopathic Scoliosis (AIS) Patient Positioning in EOS System®

Adolescent Idiopathic Scoliosis

United States
Foundation Research, Florida
GlaxoSmithKline; Abbott; Kos Pharmaceuticals

Completed

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

Insulin Resistance | Metabolic Syndrome X

United States
Rgene Corporation
American BriVision Corporation

Not yet recruiting

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Nonsquamous Nonsmall Cell Neoplasm of Lung

Taiwan
Rgene Corporation
American BriVision Corporation

Not yet recruiting

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Pancreatic Cancer
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
Guidant Corporation

Completed

MODULA Modul 5 BEAT-HF

Heart Failure

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Heart Failure

Germany
Guidant Corporation
Boston Scientific Corporation

Completed

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following (Cogent-4)

Heart Failure | Ventricular Tachycardia, Ventricular Fibrillation

Israel, Denmark
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan

Clinical Trials Sponsored by EKOS Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations